Global Intramuscular Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 111

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Intramuscular Vaccine Adjuvants market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Intramuscular Vaccine Adjuvants is used for Intramuscular injection of Vaccine Adjuvants. A vaccine adjuvant is any material which is incorporated with a vaccine for the purpose of enhancing the immune response of the vaccine. An adjuvanted vaccine will tend to have a higher, earlier, and longer-lasting immune response than a non-adjuvanted vaccine.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Intramuscular Vaccine Adjuvants industry chain, the market status of Research Applications (Infectious Diseases, Cancer), Commercial Applications (Infectious Diseases, Cancer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intramuscular Vaccine Adjuvants.

Regionally, the report analyzes the Intramuscular Vaccine Adjuvants markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intramuscular Vaccine Adjuvants market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Intramuscular Vaccine Adjuvants market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intramuscular Vaccine Adjuvants industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Infectious Diseases, Cancer).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intramuscular Vaccine Adjuvants market.

Regional Analysis: The report involves examining the Intramuscular Vaccine Adjuvants market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intramuscular Vaccine Adjuvants market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Intramuscular Vaccine Adjuvants:
Company Analysis: Report covers individual Intramuscular Vaccine Adjuvants manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intramuscular Vaccine Adjuvants This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Research Applications, Commercial Applications).

Technology Analysis: Report covers specific technologies relevant to Intramuscular Vaccine Adjuvants. It assesses the current state, advancements, and potential future developments in Intramuscular Vaccine Adjuvants areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intramuscular Vaccine Adjuvants market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Intramuscular Vaccine Adjuvants market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Infectious Diseases
Cancer
Others

Market segment by Application
Research Applications
Commercial Applications

Major players covered
GSK
Dynavax Technologies
Novavax
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intramuscular Vaccine Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intramuscular Vaccine Adjuvants, with price, sales, revenue and global market share of Intramuscular Vaccine Adjuvants from 2019 to 2024.
Chapter 3, the Intramuscular Vaccine Adjuvants competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intramuscular Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intramuscular Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intramuscular Vaccine Adjuvants.
Chapter 14 and 15, to describe Intramuscular Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Intramuscular Vaccine Adjuvants
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Intramuscular Vaccine Adjuvants Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Infectious Diseases
        1.3.3 Cancer
        1.3.4 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Intramuscular Vaccine Adjuvants Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Research Applications
        1.4.3 Commercial Applications
    1.5 Global Intramuscular Vaccine Adjuvants Market Size & Forecast
        1.5.1 Global Intramuscular Vaccine Adjuvants Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Intramuscular Vaccine Adjuvants Sales Quantity (2019-2030)
        1.5.3 Global Intramuscular Vaccine Adjuvants Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Intramuscular Vaccine Adjuvants Product and Services
        2.1.4 GSK Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 GSK Recent Developments/Updates
    2.2 Dynavax Technologies
        2.2.1 Dynavax Technologies Details
        2.2.2 Dynavax Technologies Major Business
        2.2.3 Dynavax Technologies Intramuscular Vaccine Adjuvants Product and Services
        2.2.4 Dynavax Technologies Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Dynavax Technologies Recent Developments/Updates
    2.3 Novavax
        2.3.1 Novavax Details
        2.3.2 Novavax Major Business
        2.3.3 Novavax Intramuscular Vaccine Adjuvants Product and Services
        2.3.4 Novavax Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Novavax Recent Developments/Updates
    2.4 Agenus
        2.4.1 Agenus Details
        2.4.2 Agenus Major Business
        2.4.3 Agenus Intramuscular Vaccine Adjuvants Product and Services
        2.4.4 Agenus Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Agenus Recent Developments/Updates
    2.5 Croda International
        2.5.1 Croda International Details
        2.5.2 Croda International Major Business
        2.5.3 Croda International Intramuscular Vaccine Adjuvants Product and Services
        2.5.4 Croda International Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Croda International Recent Developments/Updates
    2.6 Seppic
        2.6.1 Seppic Details
        2.6.2 Seppic Major Business
        2.6.3 Seppic Intramuscular Vaccine Adjuvants Product and Services
        2.6.4 Seppic Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Seppic Recent Developments/Updates
    2.7 OZ Biosciences
        2.7.1 OZ Biosciences Details
        2.7.2 OZ Biosciences Major Business
        2.7.3 OZ Biosciences Intramuscular Vaccine Adjuvants Product and Services
        2.7.4 OZ Biosciences Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 OZ Biosciences Recent Developments/Updates
    2.8 Phibro Animal Health
        2.8.1 Phibro Animal Health Details
        2.8.2 Phibro Animal Health Major Business
        2.8.3 Phibro Animal Health Intramuscular Vaccine Adjuvants Product and Services
        2.8.4 Phibro Animal Health Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Phibro Animal Health Recent Developments/Updates
    2.9 Associated British Foods
        2.9.1 Associated British Foods Details
        2.9.2 Associated British Foods Major Business
        2.9.3 Associated British Foods Intramuscular Vaccine Adjuvants Product and Services
        2.9.4 Associated British Foods Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Associated British Foods Recent Developments/Updates
    2.10 InvivoGen
        2.10.1 InvivoGen Details
        2.10.2 InvivoGen Major Business
        2.10.3 InvivoGen Intramuscular Vaccine Adjuvants Product and Services
        2.10.4 InvivoGen Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 InvivoGen Recent Developments/Updates
    2.11 Merck KGaA
        2.11.1 Merck KGaA Details
        2.11.2 Merck KGaA Major Business
        2.11.3 Merck KGaA Intramuscular Vaccine Adjuvants Product and Services
        2.11.4 Merck KGaA Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Merck KGaA Recent Developments/Updates
    2.12 CSL Limited
        2.12.1 CSL Limited Details
        2.12.2 CSL Limited Major Business
        2.12.3 CSL Limited Intramuscular Vaccine Adjuvants Product and Services
        2.12.4 CSL Limited Intramuscular Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 CSL Limited Recent Developments/Updates

3 Competitive Environment: Intramuscular Vaccine Adjuvants by Manufacturer
    3.1 Global Intramuscular Vaccine Adjuvants Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Intramuscular Vaccine Adjuvants Revenue by Manufacturer (2019-2024)
    3.3 Global Intramuscular Vaccine Adjuvants Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Intramuscular Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Intramuscular Vaccine Adjuvants Manufacturer Market Share in 2023
        3.4.2 Top 6 Intramuscular Vaccine Adjuvants Manufacturer Market Share in 2023
    3.5 Intramuscular Vaccine Adjuvants Market: Overall Company Footprint Analysis
        3.5.1 Intramuscular Vaccine Adjuvants Market: Region Footprint
        3.5.2 Intramuscular Vaccine Adjuvants Market: Company Product Type Footprint
        3.5.3 Intramuscular Vaccine Adjuvants Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Intramuscular Vaccine Adjuvants Market Size by Region
        4.1.1 Global Intramuscular Vaccine Adjuvants Sales Quantity by Region (2019-2030)
        4.1.2 Global Intramuscular Vaccine Adjuvants Consumption Value by Region (2019-2030)
        4.1.3 Global Intramuscular Vaccine Adjuvants Average Price by Region (2019-2030)
    4.2 North America Intramuscular Vaccine Adjuvants Consumption Value (2019-2030)
    4.3 Europe Intramuscular Vaccine Adjuvants Consumption Value (2019-2030)
    4.4 Asia-Pacific Intramuscular Vaccine Adjuvants Consumption Value (2019-2030)
    4.5 South America Intramuscular Vaccine Adjuvants Consumption Value (2019-2030)
    4.6 Middle East and Africa Intramuscular Vaccine Adjuvants Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    5.2 Global Intramuscular Vaccine Adjuvants Consumption Value by Type (2019-2030)
    5.3 Global Intramuscular Vaccine Adjuvants Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    6.2 Global Intramuscular Vaccine Adjuvants Consumption Value by Application (2019-2030)
    6.3 Global Intramuscular Vaccine Adjuvants Average Price by Application (2019-2030)

7 North America
    7.1 North America Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    7.2 North America Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    7.3 North America Intramuscular Vaccine Adjuvants Market Size by Country
        7.3.1 North America Intramuscular Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        7.3.2 North America Intramuscular Vaccine Adjuvants Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    8.2 Europe Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    8.3 Europe Intramuscular Vaccine Adjuvants Market Size by Country
        8.3.1 Europe Intramuscular Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        8.3.2 Europe Intramuscular Vaccine Adjuvants Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Intramuscular Vaccine Adjuvants Market Size by Region
        9.3.1 Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Intramuscular Vaccine Adjuvants Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    10.2 South America Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    10.3 South America Intramuscular Vaccine Adjuvants Market Size by Country
        10.3.1 South America Intramuscular Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        10.3.2 South America Intramuscular Vaccine Adjuvants Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Intramuscular Vaccine Adjuvants Market Size by Country
        11.3.1 Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Intramuscular Vaccine Adjuvants Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Intramuscular Vaccine Adjuvants Market Drivers
    12.2 Intramuscular Vaccine Adjuvants Market Restraints
    12.3 Intramuscular Vaccine Adjuvants Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Intramuscular Vaccine Adjuvants and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Intramuscular Vaccine Adjuvants
    13.3 Intramuscular Vaccine Adjuvants Production Process
    13.4 Intramuscular Vaccine Adjuvants Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Intramuscular Vaccine Adjuvants Typical Distributors
    14.3 Intramuscular Vaccine Adjuvants Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Intramuscular Vaccine Adjuvants Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Intramuscular Vaccine Adjuvants Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. GSK Basic Information, Manufacturing Base and Competitors
    Table 4. GSK Major Business
    Table 5. GSK Intramuscular Vaccine Adjuvants Product and Services
    Table 6. GSK Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. GSK Recent Developments/Updates
    Table 8. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
    Table 9. Dynavax Technologies Major Business
    Table 10. Dynavax Technologies Intramuscular Vaccine Adjuvants Product and Services
    Table 11. Dynavax Technologies Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Dynavax Technologies Recent Developments/Updates
    Table 13. Novavax Basic Information, Manufacturing Base and Competitors
    Table 14. Novavax Major Business
    Table 15. Novavax Intramuscular Vaccine Adjuvants Product and Services
    Table 16. Novavax Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Novavax Recent Developments/Updates
    Table 18. Agenus Basic Information, Manufacturing Base and Competitors
    Table 19. Agenus Major Business
    Table 20. Agenus Intramuscular Vaccine Adjuvants Product and Services
    Table 21. Agenus Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Agenus Recent Developments/Updates
    Table 23. Croda International Basic Information, Manufacturing Base and Competitors
    Table 24. Croda International Major Business
    Table 25. Croda International Intramuscular Vaccine Adjuvants Product and Services
    Table 26. Croda International Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Croda International Recent Developments/Updates
    Table 28. Seppic Basic Information, Manufacturing Base and Competitors
    Table 29. Seppic Major Business
    Table 30. Seppic Intramuscular Vaccine Adjuvants Product and Services
    Table 31. Seppic Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Seppic Recent Developments/Updates
    Table 33. OZ Biosciences Basic Information, Manufacturing Base and Competitors
    Table 34. OZ Biosciences Major Business
    Table 35. OZ Biosciences Intramuscular Vaccine Adjuvants Product and Services
    Table 36. OZ Biosciences Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. OZ Biosciences Recent Developments/Updates
    Table 38. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
    Table 39. Phibro Animal Health Major Business
    Table 40. Phibro Animal Health Intramuscular Vaccine Adjuvants Product and Services
    Table 41. Phibro Animal Health Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Phibro Animal Health Recent Developments/Updates
    Table 43. Associated British Foods Basic Information, Manufacturing Base and Competitors
    Table 44. Associated British Foods Major Business
    Table 45. Associated British Foods Intramuscular Vaccine Adjuvants Product and Services
    Table 46. Associated British Foods Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Associated British Foods Recent Developments/Updates
    Table 48. InvivoGen Basic Information, Manufacturing Base and Competitors
    Table 49. InvivoGen Major Business
    Table 50. InvivoGen Intramuscular Vaccine Adjuvants Product and Services
    Table 51. InvivoGen Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. InvivoGen Recent Developments/Updates
    Table 53. Merck KGaA Basic Information, Manufacturing Base and Competitors
    Table 54. Merck KGaA Major Business
    Table 55. Merck KGaA Intramuscular Vaccine Adjuvants Product and Services
    Table 56. Merck KGaA Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Merck KGaA Recent Developments/Updates
    Table 58. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 59. CSL Limited Major Business
    Table 60. CSL Limited Intramuscular Vaccine Adjuvants Product and Services
    Table 61. CSL Limited Intramuscular Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. CSL Limited Recent Developments/Updates
    Table 63. Global Intramuscular Vaccine Adjuvants Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 64. Global Intramuscular Vaccine Adjuvants Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 65. Global Intramuscular Vaccine Adjuvants Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 66. Market Position of Manufacturers in Intramuscular Vaccine Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 67. Head Office and Intramuscular Vaccine Adjuvants Production Site of Key Manufacturer
    Table 68. Intramuscular Vaccine Adjuvants Market: Company Product Type Footprint
    Table 69. Intramuscular Vaccine Adjuvants Market: Company Product Application Footprint
    Table 70. Intramuscular Vaccine Adjuvants New Market Entrants and Barriers to Market Entry
    Table 71. Intramuscular Vaccine Adjuvants Mergers, Acquisition, Agreements, and Collaborations
    Table 72. Global Intramuscular Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (K Units)
    Table 73. Global Intramuscular Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (K Units)
    Table 74. Global Intramuscular Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
    Table 75. Global Intramuscular Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
    Table 76. Global Intramuscular Vaccine Adjuvants Average Price by Region (2019-2024) & (US$/Unit)
    Table 77. Global Intramuscular Vaccine Adjuvants Average Price by Region (2025-2030) & (US$/Unit)
    Table 78. Global Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 79. Global Intramuscular Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 80. Global Intramuscular Vaccine Adjuvants Consumption Value by Type (2019-2024) & (USD Million)
    Table 81. Global Intramuscular Vaccine Adjuvants Consumption Value by Type (2025-2030) & (USD Million)
    Table 82. Global Intramuscular Vaccine Adjuvants Average Price by Type (2019-2024) & (US$/Unit)
    Table 83. Global Intramuscular Vaccine Adjuvants Average Price by Type (2025-2030) & (US$/Unit)
    Table 84. Global Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 85. Global Intramuscular Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 86. Global Intramuscular Vaccine Adjuvants Consumption Value by Application (2019-2024) & (USD Million)
    Table 87. Global Intramuscular Vaccine Adjuvants Consumption Value by Application (2025-2030) & (USD Million)
    Table 88. Global Intramuscular Vaccine Adjuvants Average Price by Application (2019-2024) & (US$/Unit)
    Table 89. Global Intramuscular Vaccine Adjuvants Average Price by Application (2025-2030) & (US$/Unit)
    Table 90. North America Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 91. North America Intramuscular Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 92. North America Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 93. North America Intramuscular Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 94. North America Intramuscular Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (K Units)
    Table 95. North America Intramuscular Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (K Units)
    Table 96. North America Intramuscular Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
    Table 97. North America Intramuscular Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
    Table 98. Europe Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 99. Europe Intramuscular Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 100. Europe Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 101. Europe Intramuscular Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 102. Europe Intramuscular Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (K Units)
    Table 103. Europe Intramuscular Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (K Units)
    Table 104. Europe Intramuscular Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
    Table 105. Europe Intramuscular Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
    Table 106. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 107. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 108. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 109. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 110. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (K Units)
    Table 111. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (K Units)
    Table 112. Asia-Pacific Intramuscular Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
    Table 113. Asia-Pacific Intramuscular Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
    Table 114. South America Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 115. South America Intramuscular Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 116. South America Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 117. South America Intramuscular Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 118. South America Intramuscular Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (K Units)
    Table 119. South America Intramuscular Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (K Units)
    Table 120. South America Intramuscular Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
    Table 121. South America Intramuscular Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
    Table 122. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 123. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 124. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 125. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 126. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (K Units)
    Table 127. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (K Units)
    Table 128. Middle East & Africa Intramuscular Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
    Table 129. Middle East & Africa Intramuscular Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
    Table 130. Intramuscular Vaccine Adjuvants Raw Material
    Table 131. Key Manufacturers of Intramuscular Vaccine Adjuvants Raw Materials
    Table 132. Intramuscular Vaccine Adjuvants Typical Distributors
    Table 133. Intramuscular Vaccine Adjuvants Typical Customers
List of Figures
    Figure 1. Intramuscular Vaccine Adjuvants Picture
    Figure 2. Global Intramuscular Vaccine Adjuvants Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Intramuscular Vaccine Adjuvants Consumption Value Market Share by Type in 2023
    Figure 4. Infectious Diseases Examples
    Figure 5. Cancer Examples
    Figure 6. Others Examples
    Figure 7. Global Intramuscular Vaccine Adjuvants Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 8. Global Intramuscular Vaccine Adjuvants Consumption Value Market Share by Application in 2023
    Figure 9. Research Applications Examples
    Figure 10. Commercial Applications Examples
    Figure 11. Global Intramuscular Vaccine Adjuvants Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Intramuscular Vaccine Adjuvants Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Intramuscular Vaccine Adjuvants Sales Quantity (2019-2030) & (K Units)
    Figure 14. Global Intramuscular Vaccine Adjuvants Average Price (2019-2030) & (US$/Unit)
    Figure 15. Global Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Manufacturer in 2023
    Figure 16. Global Intramuscular Vaccine Adjuvants Consumption Value Market Share by Manufacturer in 2023
    Figure 17. Producer Shipments of Intramuscular Vaccine Adjuvants by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 18. Top 3 Intramuscular Vaccine Adjuvants Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Top 6 Intramuscular Vaccine Adjuvants Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Global Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
    Figure 21. Global Intramuscular Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
    Figure 22. North America Intramuscular Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 23. Europe Intramuscular Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 24. Asia-Pacific Intramuscular Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 25. South America Intramuscular Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 26. Middle East & Africa Intramuscular Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 27. Global Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 28. Global Intramuscular Vaccine Adjuvants Consumption Value Market Share by Type (2019-2030)
    Figure 29. Global Intramuscular Vaccine Adjuvants Average Price by Type (2019-2030) & (US$/Unit)
    Figure 30. Global Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 31. Global Intramuscular Vaccine Adjuvants Consumption Value Market Share by Application (2019-2030)
    Figure 32. Global Intramuscular Vaccine Adjuvants Average Price by Application (2019-2030) & (US$/Unit)
    Figure 33. North America Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 34. North America Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 35. North America Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
    Figure 36. North America Intramuscular Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Canada Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Mexico Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Europe Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 41. Europe Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 42. Europe Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
    Figure 43. Europe Intramuscular Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
    Figure 44. Germany Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. France Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. United Kingdom Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Russia Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Italy Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 50. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 51. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
    Figure 52. Asia-Pacific Intramuscular Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
    Figure 53. China Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Japan Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Korea Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. India Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Southeast Asia Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Australia Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. South America Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 60. South America Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 61. South America Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
    Figure 62. South America Intramuscular Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
    Figure 63. Brazil Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Argentina Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 66. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 67. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
    Figure 68. Middle East & Africa Intramuscular Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
    Figure 69. Turkey Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Egypt Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Saudi Arabia Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. South Africa Intramuscular Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Intramuscular Vaccine Adjuvants Market Drivers
    Figure 74. Intramuscular Vaccine Adjuvants Market Restraints
    Figure 75. Intramuscular Vaccine Adjuvants Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Intramuscular Vaccine Adjuvants in 2023
    Figure 78. Manufacturing Process Analysis of Intramuscular Vaccine Adjuvants
    Figure 79. Intramuscular Vaccine Adjuvants Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GSK
Dynavax Technologies
Novavax
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited

Related Reports

Global Intramuscular Vaccine Adjuvants Supply, Demand and Key Producers, 2023-2029

Global Intramuscular Vaccine Adjuvants Supply, Demand and Key Producers, 2023-2029

date 04 Feb 2023

date Pharma & Healthcare

The global Intramuscular Vaccine Adjuvants market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Intramuscular Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

Global Intramuscular Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

The global Intramuscular Vaccine Adjuvants market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Intramuscular Vaccine Adjuvants

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>